Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Procter & Gamble reported for 3 months of fiscal year 2024

10/18/23 PG

Sitronics has released a pre-production sample charging station

10/18/23 AFKS

Severstal to build a pellet production complex in Cherepovets

10/18/23 CHMF

Gazprom expects to increase supplies to China to the volume of exports to Europe

10/18/23 GAZP

Genetico opened a new medical center in Medtech Moscow

10/18/23 GECO

Transneft reported for 9 months of 2023 by RAS

10/18/23 TRNFP

MMK increased steel production by 11.4%

10/18/23 MAGN

Novatek started construction of the third line of Arctic LNG 2

10/18/23 NVTK

Board of Directors of Whoosh recommended that dividends be paid for 9 months 2023

10/18/23 WUSH

Board of Directors of EvroTrans recommended that dividends be paid for 9 months 2023

10/18/23 EUTR